Shares of other companies:
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
April 12, 2024 Banks Brace for Earnings Amid Rate Cut Speculations
Apple’s Technical Climb To $240 By Year-End
April 15, 2024
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
MDT Stock News and Mentions of Medtronic plc. Stocktwits
Updated: April 18, 2024 (13:16)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Medtronic Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Medtronic plc. (MDT).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Medtronic stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Medtronic plc. (MDT)
April 18, 2024 (17:00) / "Benzinga" (by Benzinga Insights)
Looking Into Medtronic's Recent Short Interest - Medtronic ( NYSE:MDT )
Medtronic's MDT short percent of float has risen 8.05% since its last report. The company recently reported that it has 12.43 million shares sold short, which is 0.94% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.18 days to cover their ...
In Article Trend: Somewhat-Bullish
April 18, 2024 (15:09) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Medtronic ( MDT ) Stock for Now
Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.
In Article Trend: Somewhat-Bullish
April 18, 2024 (13:05) / "Motley Fool" (by David Jagielski)
Medtronic Stock: Buy, Sell, or Hold?
Can this struggling healthcare specialist turn things around?
In Article Trend: Bullish
April 17, 2024 (14:30) / "Benzinga" (by Globe Newswire)
Blood Collection Market size worth $ 14.76 Billion, Globally, by 2031 at 5.10% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, April 17, 2024 ( GLOBE NEWSWIRE ) -- The Global Blood Collection Market is projected to grow at a CAGR of 5.10% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Somewhat-Bullish
April 17, 2024 (10:00) / "Zacks Commentary" (by Zacks Investment Research)
The Zacks Analyst Blog Highlights Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic
Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic are included in this Analyst Blog.
In Article Trend: Somewhat-Bullish
April 16, 2024 (21:50) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Stock Sinks As Market Gains: What You Should Know
Medtronic (MDT) concluded the recent trading session at $79.35, signifying a -1.1% move from its prior day's close.
In Article Trend: Neutral
April 16, 2024 (13:00) / "PR Newswire"
Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO - PR Newswire
Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO PR ...
In Article Trend: Somewhat-Bullish
April 16, 2024 (08:55) / "Motley Fool" (by Adria Cimino)
2 Artificial Intelligence ( AI ) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
These companies have gotten in on AI early and could emerge as winners.
In Article Trend: Bullish
April 16, 2024 (00:34) / "Forbes" (by John Navin)
These 4 NYSE Stocks Just Broke Below Previous Price Support
When buyers fail to show up at the price where they previously paid, it's a sign of weakness for a stock. You don't need a thorough understanding of technical analysis to appreciate this. It's not that much different than a goods store marking down merchandise since it's not being purchased at ...
In Article Trend: Neutral
April 15, 2024 (18:42) / "Benzinga" (by Vandana Singh)
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA Why Is Medical Device Manufacture Integer Stock Gaining Today? - Integer Holdings ( NYSE:ITGR )
BofA Securities upgraded Integer Holdings Corporation ITGR, citing the anticipated growth in pulsed field ablation ( PFA ) for treating atrial fibrillation. Integer is one of the largest medical device outsourcing manufacturers, serving the cardiac rhythm management, neuromodulation, ...
In Article Trend: Somewhat-Bullish
April 15, 2024 (14:15) / "Benzinga" (by Globe Newswire)
Wearable Injectors Market size worth $ 21.48 Billion, Globally, by 2031 at 15.30% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, April 15, 2024 ( GLOBE NEWSWIRE ) -- The Global Wearable Injectors Market is projected to grow at a CAGR of 15.30% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Somewhat-Bullish
April 13, 2024 (11:24) / "CNBC" (by Kenneth Squire)
Third Point, Saddle Point win board seats at Advance Auto Parts. A plan to improve margins may unfold
The two activists recently picked up three board seats at the auto parts retailer.
In Article Trend: Neutral
April 12, 2024 (13:00) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic PLC ( MDT ) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In Article Trend: Somewhat-Bullish
April 11, 2024 (13:31) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic's ( MDT ) Sphere-360 PFA Study Outcome Favorable
Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.
In Article Trend: Somewhat-Bullish
April 11, 2024 (10:45) / "Benzinga" (by Zacks)
Boston Scientific ( BSX ) Faces Rising Costs, Competition - Boston Scientific ( NYSE:BSX ) , Cardinal Health ( NYSE:CAH )
Boston Scientific Corporation BSX has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in the large medical device market also pose a tough challenge for Boston Scientific. The stock carries a Zacks Rank #4 ( Sell ) currently.
In Article Trend: Neutral
April 11, 2024 (10:15) / "Motley Fool" (by Prosper Junior Bakiny)
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
These companies provide stability, reliability, and passive income.
In Article Trend: Somewhat-Bullish
April 11, 2024 (10:05) / "Motley Fool" (by Adria Cimino)
Here Are My Top Artificial Intelligence ( AI ) Stocks to Buy Now
These three players offer you a great entry point right now.
In Article Trend: Bullish
April 10, 2024 (23:40) / "Investing News Network" (by Investing News Network)
CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials
AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy
In Article Trend: Bullish
April 10, 2024 (21:50) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Falls More Steeply Than Broader Market: What Investors Need to Know
Medtronic (MDT) reachead $82.33 at the closing of the latest trading day, reflecting a -1.75% change compared to its last close.
In Article Trend: Neutral
April 10, 2024 (13:39) / "Business Insider" (by Avi Kapoor)
Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Medtronic ( NYSE:MDT ) . "I like what they're doing in AI. You've got a good one with a good yield," he noted. On March 27, the FDA approved Medtronic's Evolut FX+ transcatheter aortic valve replacement ( TAVR ) system for ...
In Article Trend: Somewhat-Bullish
April 10, 2024 (13:30) / "Zacks Commentary" (by Zacks Equity Research)
Boston Scientific ( BSX ) Faces Rising Costs, Competition
With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.
In Article Trend: Neutral
April 10, 2024 (13:18) / "Benzinga" (by Avi Kapoor)
Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20 - Cleveland-Cliffs ( NYSE:CLF ) , Medtronic ( NYSE:MDT )
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Medtronic MDT. "I like what they're doing in AI. You've got a good one with a good yield," he noted. On March 27, the FDA approved Medtronic's Evolut FX+ transcatheter aortic valve replacement ( TAVR ) system for symptomatic ...
In Article Trend: Somewhat-Bullish
April 9, 2024 (00:15) / "Benzinga" (by Globe Newswire)
ThoughtSpot Named Google Cloud Technology Partner of the Year for Data - Business Intelligence
MOUNTAIN VIEW, Calif., April 08, 2024 ( GLOBE NEWSWIRE ) -- ThoughtSpot, the AI-Powered Analytics company, today announced it has been named the 2024 Google Cloud Technology Partner of the Year Award for Data - Business Intelligence.
In Article Trend: Somewhat-Bullish
April 8, 2024 (14:00) / "Benzinga" (by Globe Newswire)
mHealth Market size worth $ 122.50 Billion, Globally, by 2031 at 10.54% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, April 08, 2024 ( GLOBE NEWSWIRE ) -- The Global mHealth Solutions Market is projected to grow at a CAGR of 10.54% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Bullish
April 8, 2024 (12:40) / "Investing News Network" (by Investing News Network)
The Medtronic Sphere-360 Pulse Field Ablation catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation
The Medtronic Sphere-360 Pulse Field Ablation catheter, a new paradigm in single-shot ablation, demonstrates ... Investing News Network ...
In Article Trend: Somewhat-Bullish
April 8, 2024 (12:00) / "Canada Newswire"
The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation ... - Canada NewsWire
The Medtronic Sphere-360™ Pulse Field Ablation ( PFA ) catheter, a new paradigm in single-shot ablation ... Canada ...
In Article Trend: Somewhat-Bullish
April 7, 2024 (13:45) / "PR Newswire" (by Medtronic plc)
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic ... PR ...
In Article Trend: Somewhat-Bullish
April 7, 2024 (13:45) / "Canada Newswire" (by Medtronic plc)
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic ... Canada ...
In Article Trend: Somewhat-Bullish
April 7, 2024 (12:00) / "PR Newswire" (by Medtronic plc)
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities for awareness amongst women at risk for cardiovascular disease
In Article Trend: Somewhat-Bullish
April 7, 2024 (12:00) / "Canada Newswire" (by Medtronic plc)
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities for awareness amongst women at risk for cardiovascular disease
In Article Trend: Somewhat-Bullish
April 4, 2024 (21:50) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Registers a Bigger Fall Than the Market: Important Facts to Note
In the closing of the recent trading day, Medtronic (MDT) stood at $83.92, denoting a -1.27% change from the preceding trading day.
In Article Trend: Neutral
April 4, 2024 (17:29) / "Benzinga" (by Zacks)
Globus Medical ( GMED ) Gains From New Launches Amid Macro Issues - DaVita ( NYSE:DVA ) , Cardinal Health ( NYSE:CAH )
Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company is expanding in the overseas markets through the expansion of direct and distributor sales force.
In Article Trend: Somewhat-Bullish
April 4, 2024 (12:41) / "Zacks Commentary" (by Zacks Equity Research)
Globus Medical ( GMED ) Gains From New Launches Amid Macro Issues
Globus Medical (GMED) witnesses notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.
In Article Trend: Somewhat-Bullish
April 3, 2024 (15:30) / "Benzinga" (by Globe Newswire)
Transformative Growth Expected In The Global Medical Equipment Market: Market Size To Reach $1,077 Billion By 2028 As Per The Business Research Company's Medical Equipment Global Market Report 2024
LONDON, April 03, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Medical Equipment Global Market Report 2024, the medical equipment market has witnessed robust growth in recent years, with the market size expected to reach $775.42 billion in 2024, reflecting a compound annual ...
In Article Trend: Somewhat-Bullish
April 3, 2024 (10:20) / "Zacks Commentary" (by Zacks Equity Research)
Should You Invest in the iShares U.S. Medical Devices ETF ( IHI ) ?
Sector ETF report for IHI ...
In Article Trend: Somewhat-Bullish
April 2, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Electroceuticals/Bioelectric Medicine Market is Expected to Reach $33.6 billion | MarketsandMarkets™
Chicago, April 02, 2024 ( GLOBE NEWSWIRE ) -- Electroceuticals/Bioelectric Medicine market in terms of revenue was estimated to be worth $23.9 billion in 2024 and is poised to reach $33.6 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2029 according to a latest report published by ...
In Article Trend: Somewhat-Bullish
April 2, 2024 (05:54) / "GlobeNewswire" (by BioPorto A/S)
BioPorto appoints Peter Mørch Eriksen as permanent Group Chief Executive Officer
April 2, 2024Announcement no. ...
In Article Trend: Somewhat-Bullish
April 1, 2024 (20:05) / "Benzinga" (by Globe Newswire)
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results - Acutus Medical ( NASDAQ:AFIB )
CARLSBAD, Calif., April 01, 2024 ( GLOBE NEWSWIRE ) -- Acutus Medical, Inc. ( "Acutus" or the "Company" ) AFIB today reported results for the fourth quarter and full year ended December 31,2023.
In Article Trend: Somewhat-Bullish
April 1, 2024 (14:41) / "Zacks Commentary" (by Zacks Equity Research)
Tandem Diabetes ( TNDM ) Gains From Innovation Amid Macro Issues
Tandem Diabetes (TNDM) seeks to grow its business through the acquisition of products or technologies and investments in businesses.
In Article Trend: Somewhat-Bullish
April 1, 2024 (12:15) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic's ( MDT ) Newest Evolut TAVR System Gets FDA Approval
Medtronic (MDT) announces the FDA approval of the newest-generation Evolut TAVR system for the treatment of symptomatic severe aortic stenosis.
In Article Trend: Somewhat-Bullish
March 31, 2024 (18:17) / "Motley Fool" (by Cory Renauer)
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance
Which dividend-paying healthcare stock is better positioned to produce a rapidly growing payout?
In Article Trend: Neutral
March 31, 2024 (11:45) / "Motley Fool" (by Prosper Junior Bakiny)
2 Healthcare Artificial Intelligence ( AI ) Stocks That Could Be Smart Investment Bets
There are many ways to cash in on the rise of AI.
In Article Trend: Somewhat-Bullish
March 31, 2024 (10:20) / "Motley Fool" (by Selena Maranjian)
The Smartest Dividend Stocks to Buy With $400 Right Now
Dividend-payers aren't just for your grandparents -- they actually outperform non-payers, according to one study.
In Article Trend: Somewhat-Bullish
March 30, 2024 (09:19) / "Motley Fool" (by Cory Renauer)
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
These advantaged businesses have what it takes to keep raising their payouts.
In Article Trend: Somewhat-Bullish
March 29, 2024 (21:41) / "GlobeNewswire" (by Titan Medical Inc.)
Titan Medical Reports Fiscal Year 2023 Results
TORONTO, Ontario, March 29, 2024 ( GLOBE NEWSWIRE ) -- Titan Medical Inc. ( "Titan" or the "Company" ) ( TSX: TMD. OTC: TMDIF ) , today reported financial results for the fiscal year ended December 31, 2023.
In Article Trend: Somewhat-Bullish
March 28, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)
National Vision ( EYE ) Down 4.1% Since Last Earnings Report: Can It Rebound?
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 28, 2024 (14:02) / "Zacks Commentary" (by Zacks Equity Research)
Shockwave Medical ( SWAV ) Up on Potential Acquisition Rumors
Shockwave Medical's (SWAV) shares gain as rumors about its potential acquisition by an industry giant get media attention.
In Article Trend: Somewhat-Bullish
March 28, 2024 (05:30) / "Barrons" (by Andy Serwer)
Ben & Jerry's Long, Strange Trip to a Multibillion-Dollar Valuation
In a game of word association, "ice cream" and "complexity" might not leap to mind, but these days they should. You probably saw last week that global goliath Unilever said it was looking to jettison its ice cream business, which includes America's grooviest company, Ben & Jerry's.
In Article Trend: Neutral
March 27, 2024 (20:23) / "Benzinga" (by Vandana Singh)
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst - Boston Scientific ( NYSE:BSX ) , Johnson & Johnson ( NYSE:JNJ ) , Medtronic ( NYSE:MDT ) , Shockwave Medical ( NASDAQ:SWAV )
Tuesday, Shockwave Medical Inc SWAV shares traded higher following a Wall Street Journal report suggesting Johnson & Johnson JNJ is reportedly in talks to acquire the company. Shockwave Medical is a cardiovascular medical device.
In Article Trend: Somewhat-Bullish
March 27, 2024 (20:17) / "GlobeNewswire" (by Orchestra BioMed Holdings)
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
NEW HOPE, Pa., March 27, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2023 financial ...
In Article Trend: Somewhat-Bullish
March 27, 2024 (18:14) / "Benzinga" (by Vandana Singh)
Why Is Medtronic Stock Trading Higher On Wednesday? - Medtronic ( NYSE:MDT )
Wednesday, the FDA approved Medtronic plc's MDT Evolut FX+ transcatheter aortic valve replacement ( TAVR ) system for symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate ...
In Article Trend: Somewhat-Bullish
March 27, 2024 (16:23) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Buy Zimmer Biomet ( ZBH ) Stock Now
Investors are optimistic about Zimmer Biomet (ZBH), led by expansion in the knee business and recovery across the business.
In Article Trend: Somewhat-Bullish
March 27, 2024 (12:45) / "Investing News Network" (by Investing News Network)
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe ... Investing News Network ...
In Article Trend: Somewhat-Bullish
March 27, 2024 (12:00) / "Canada Newswire"
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe ... - Canada NewsWire
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe ... Canada ...
In Article Trend: Somewhat-Bullish
March 27, 2024 (08:50) / "Motley Fool" (by Adria Cimino)
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
Each of these three companies are entering a new era of growth.
In Article Trend: Somewhat-Bullish
March 26, 2024 (14:00) / "Motley Fool" (by Adria Cimino)
Prediction: Healthcare Stocks Could Become the Biggest Winners of the Artificial Intelligence ( AI ) Boom and Here's Why.
A key player in AI is very optimistic about the technology's potential in healthcare.
In Article Trend: Bullish
March 26, 2024 (12:00) / "GlobeNewswire" (by Inc.)
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
NEW HOPE, Pa., March 26, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the appointment of David ...
In Article Trend: Somewhat-Bullish
March 25, 2024 (13:15) / "Zacks Commentary" (by Zacks Equity Research)
Abbott ( ABT ) Expands in Canada With First Eterna SCS Use
Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.
In Article Trend: Somewhat-Bullish
March 25, 2024 (06:00) / "Business Insider" (by markets.businessinsider.com)
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
Paris, France and Munich, Germany, March 25, 2024 - TRiCares SAS ( "TRiCares" ) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer ( CEO ) .
In Article Trend: Somewhat-Bullish
March 24, 2024 (23:47) / "Investing News Network" (by Investing News Network)
Peer-Review Further Supports CLEO's Ovarian Cancer Detection Technology
Medtronic moves for patent infringement litigation to resume Medtronic ( NYSE:MDT ) , the global leader in healthcare technology, today announced that the Patent Trial and Appeal Board ( PTAB ) of the U.S.
In Article Trend: Somewhat-Bearish
March 23, 2024 (07:46) / "Motley Fool" (by Adria Cimino)
Artificial Intelligence ( AI ) in Healthcare: 2 Top Stock Picks
These particular healthcare stocks are dirt cheap now considering their AI potential.
In Article Trend: Bullish
March 22, 2024 (16:24) / "Zacks Commentary" (by Zacks Equity Research)
Tandem Diabetes ( TNDM ) Gains From Innovation Amid Competition
Tandem Diabetes (TNDM), in 2024, intends to advance its AID algorithm and expand its indications to include people living with Type 2 diabetes.
In Article Trend: Somewhat-Bullish
March 21, 2024 (18:51) / "Canada Newswire" (by Medtronic plc)
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
DUBLIN, March 21, 2024 /CNW/ -- Medtronic ( NYSE:MDT ) , the global leader in healthcare technology, today announced that the Patent Trial and Appeal Board ( PTAB ) of the U.S.
In Article Trend: Neutral
March 21, 2024 (17:15) / "Benzinga" (by Benzinga Insights)
Looking Into Medtronic's Recent Short Interest - Medtronic ( NYSE:MDT )
Medtronic's MDT short percent of float has fallen 9.76% since its last report. The company recently reported that it has 9.81 million shares sold short, which is 0.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.77 days to cover their ...
In Article Trend: Somewhat-Bullish
March 21, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Down 2.2% Since Last Earnings Report: Can It Rebound?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Somewhat-Bullish
March 21, 2024 (13:45) / "Motley Fool" (by Prosper Junior Bakiny)
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
These stocks have been providing excellent returns for a long time.
In Article Trend: Bullish
March 21, 2024 (12:45) / "Motley Fool" (by Prosper Junior Bakiny)
1 Magnificent Growth Stock to Buy and Hold
Investing in this company 10 years ago would have produced excellent returns, but it's not too late -- far from it.
In Article Trend: Somewhat-Bullish
March 20, 2024 (21:45) / "CNN" (by Jacqueline Howard)
People with darker skin are 32% more likely to have pulse oximeter readings overestimate oxygen levels, report says
Scientists have long known that pulse oximeters are less accurate when used for people with dark skin tones - and now, a new report offers some insight into just how much more inaccurate these fingertip clamps can be.
In Article Trend: Neutral
March 20, 2024 (03:03) / "Benzinga" (by Benzinga Neuro)
Jim Cramer Reveals Nvidia's Non-Tech Partners That Can Be Potential Market Winner: 'Best Opportunities' - Getty Images Holdings ( NYSE:GETY ) , GE HealthCare Techs ( NASDAQ:GEHC )
CNBC host Jim Cramer has spotlighted several lesser-known partners of NVIDIA Corp NVDA that could potentially benefit from the company's advanced artificial intelligence ( AI ) technology.
In Article Trend: Somewhat-Bullish
March 19, 2024 (15:40) / "Benzinga" (by Globe Newswire)
Cartilage Repair Market Anticipates Rapid Growth, Projected To Reach $2.3 Billion In 2028 As Per The Business Research Company's Cartilage Repair Global Market Report 2024
LONDON, March 19, 2024 ( GLOBE NEWSWIRE ) -- The Business Research Company's Cartilage Repair Market Global Report 2024 forecasts significant growth, with the cartilage repair market size expected to rise from $1.24 billion in 2023 to $1.42 billion in 2024, demonstrating a compound annual growth ...
In Article Trend: Somewhat-Bullish
March 19, 2024 (15:40) / "Benzinga" (by Globe Newswire)
Cardiovascular Implants Market Poised For Strong Growth, Reaching $34.5 Billion In 2028: Latest Report Unveils Insights As Per The Business Research Company's Cardiovascular Implants Global Market Report 2024
LONDON, March 19, 2024 ( GLOBE NEWSWIRE ) -- The global cardiovascular implants market is experiencing robust growth, as highlighted in the newest report "Cardiovascular Implants Market Global Report 2024", by The Business Research Company.
In Article Trend: Bullish
March 18, 2024 (12:23) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Buy Insulet ( PODD ) Stock Right Now
Investors remain confident in the Insulet (PODD) stock due to the huge success of Omnipod 5.
In Article Trend: Somewhat-Bullish
March 18, 2024 (07:30) / "Motley Fool" (by Adria Cimino)
Here Are My Top Artificial Intelligence ( AI ) Stocks to Buy in March
AI already is boosting revenue at these companies...
In Article Trend: Somewhat-Bullish
March 17, 2024 (08:45) / "Motley Fool" (by Chuck Saletta)
3 Companies With Strong Irish Operations
St. Patrick's Day provides the perfect opportunity to raise a toast to some of the great companies that operate from the Emerald Isle.
In Article Trend: Somewhat-Bullish
March 15, 2024 (17:17) / "Barrons" (by Teresa Rivas)
Think Stock Prices Are Too High? 5 Ways to Prepare for a Drop.
Think the Market Is Too Hot? 5 Ways to Get Defensive Now. ...
In Article Trend: Somewhat-Bullish
March 15, 2024 (13:32) / "PR Newswire" (by Fortune Media (USA) Corporation)
Fortune Launches First Innovation Forum in Hong Kong March 27- 28
All new annual conference on critical issues in tech, finance, talent and energy, with a spotlight on Asia and convening industry leaders and investors from some of the world's most dynamic companies Over 60 speakers, including top executives from Google, Amazon, Intel, Nike, Rakuten, Walmart, ...
In Article Trend: Bullish
March 14, 2024 (05:49) / "Investing News Network" (by Investing News Network)
Funding Commitment Agreement Update
Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced two oral presentations were given at the Cardiovascular Research Technologies ( ...
In Article Trend: Neutral
March 13, 2024 (16:04) / "Investors Business Daily" (by ALLISON GATLIN)
IBD Stock Of The Day Lingers In Buy Zone As Diabetes Play Eyes Obesity
Dexcom ( DXCM ) is Wednesday's IBD Stock Of The Day. Dexcom stock is lingering in a buy zone, bolstered by U.S. clearance of a new body-worn glucose monitor. The company developed Stelo, its newest continuous glucose monitor, for the roughly 25 million people in the U.S. with type 2 diabetes ...
In Article Trend: Neutral
March 13, 2024 (16:01) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Globus Medical ( GMED ) Stock Now
Investors are optimistic about Globus Medical (GMED), led by growth in the U.S. spine business and progress in the recently merged NuVasive business.
In Article Trend: Somewhat-Bullish
March 12, 2024 (12:03) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Medtronic ( MDT ) Stock for Now
Investors continue to be optimistic about Medtronic (MDT) on the strength of the Neurosurgery and Cardiovascular and Neurosurgery portfolios.
In Article Trend: Somewhat-Bullish
March 11, 2024 (13:17) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic's ( MDT ) MiniMed 780G System Study Data Favorable
Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.
In Article Trend: Somewhat-Bullish
March 11, 2024 (08:16) / "PR Newswire"
Surgical Sutures Market size is set to grow by USD 1102.57 mn from 2023-2027. Increase in volume of surgeries boost ... - PR Newswire
Surgical Sutures Market size is set to grow by USD 1102.57 mn from 2023-2027. Increase in volume of surgeries boost ... PR ...
In Article Trend: Neutral
March 9, 2024 (11:35) / "Investing News Network" (by Investing News Network)
New real-world data shows MiniMed 780G system sustains strong global performance, exceeding international targets for diabetes management
New real-world data shows MiniMed 780G system sustains strong global performance, exceeding international targets ... Investing News Network ...
In Article Trend: Somewhat-Bullish
March 9, 2024 (10:40) / "PR Newswire"
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international ... - PR Newswire
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international ... PR ...
In Article Trend: Somewhat-Bullish
March 8, 2024 (14:15) / "Motley Fool" (by David Jagielski)
2 Medical Device Stocks to Buy Hand Over Fist in March
Don't let their modest gains over the past year mislead you. these stocks can make for great long-term investments.
In Article Trend: Bullish
March 7, 2024 (19:57) / "Benzinga" (by Vandana Singh)
Medtronic Recalls Neurosurgery Catheter Tubing, FDA Identifies As Serious Recall - Medtronic ( NYSE:MDT )
Medtronic Plc's MDT Neurosurgery unit on Thursday said it is recalling the Duet External Drainage and Monitoring System ( EDMS ) catheter tubing due to a potential for the catheter disconnection from the patient line stopcock connectors.
In Article Trend: Somewhat-Bearish
March 7, 2024 (13:00) / "GlobeNewswire" (by Orchestra BioMed Holdings)
Orchestra BioMed to Participate in Upcoming Investor Conferences
NEW HOPE, Pa., March 07, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management ...
In Article Trend: Neutral
March 6, 2024 (22:48) / "Forbes" (by Katie Jennings)
InnovationRx: Biopharma VCs Placed Fewer But Surer Bets In 2023
Biopharma venture capitalists placed fewer bets in 2023, per PitchBook Forbes ...
In Article Trend: Neutral
March 6, 2024 (13:37) / "GlobeNewswire" (by Orchestra BioMed Holdings)
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients
NEW HOPE, Pa., March 06, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the presentation of new ...
In Article Trend: Neutral
March 5, 2024 (11:37) / "Motley Fool" (by Cory Renauer)
3 High-Yield S&P 500 Dividend Stocks Down More Than 28% to Buy Now and Hold at Least a Decade
Each of these companies has decades-long consecutive annual dividend-raising streaks.
In Article Trend: Somewhat-Bullish
March 4, 2024 (13:05) / "Benzinga" (by Globe Newswire)
Global Urinary Incontinence Treatment Devices Market Size is Estimated to Reach USD 6.02 billion by 2030, Growing at a CAGR of 6.58%: Straits Research
New York, United States, March 04, 2024 ( GLOBE NEWSWIRE ) -- A medical disease called urinary incontinence causes uncontrollable urine loss. Medical devices are used to treat chronic urine incontinence and to grow and strengthen the pelvic floor muscles.
In Article Trend: Neutral
February 29, 2024 (16:30) / "Benzinga" (by Globe Newswire)
Endoscopic Camera Market Size Is Expected To Grow At A Rate Of More Than 9% Through 2024-2028 As Per The Business Research Company's Endoscopic Camera Global Market Report 2024
LONDON, Feb. 29, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Endoscopic Camera Global Market Report 2024, the endoscopic camera market has witnessed robust growth in recent years, with significant advancements in minimally invasive surgery, medical training, and patient ...
In Article Trend: Somewhat-Bullish
February 28, 2024 (14:12) / "Zacks Commentary" (by Zacks Equity Research)
The Zacks Analyst Blog Highlights Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic
Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic are part of the Zacks top Analyst Blog.
In Article Trend: Somewhat-Bullish
February 28, 2024 (10:02) / "Benzinga" (by Globe Newswire)
Intracranial Stents Market Projected to Achieve USD 3.4 billion by 2031, with a 5.2% CAGR Growth: Transparency Market Research, Inc.
Wilmington, Delaware, United States, Feb. 28, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global intracranial stents market is projected to grow at a CAGR of 5.2% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 3.4 billion is anticipated for the ...
In Article Trend: Somewhat-Bullish
February 27, 2024 (22:40) / "Forbes" (by Dileep Rao)
Mark Cuban's Surprising Advice: Should Entrepreneurs Heed It?
Mark Cuban started his first venture at the age of 12 to sell garbage bags. He started his second venture, MicroSolutions after he graduated from college, and then sold it to H&R Block for $6 million in 1990. He then joined his third venture, Broadcast.com, with Chris Jaeb and Todd Wagner in ...
In Article Trend: Somewhat-Bullish
February 27, 2024 (18:30) / "CNBC" (by Rohan Goswami)
Norfolk Southern proxy fight draws heavyweight politicians and regulatory scrutiny a year after derailment
Ancora is seeking to oust Norfolk Southern CEO Alan Shaw in a proxy fight, and bigwig politicians are lining up on either side of the battle.
In Article Trend: Neutral
February 26, 2024 (16:54) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Buy Edward Lifesciences ( EW ) Stock Now
Investors are optimistic about Edward Lifesciences' (EW) progress with the Structural Heart business and strong TAVR potential.
In Article Trend: Somewhat-Bullish
February 26, 2024 (15:33) / "Benzinga" (by Globe Newswire)
Pediatric Medical Devices Market Set to Hit USD 47.4 billion by 2031, with 6.3% CAGR: Analysis by Transparency Market Research, Inc.
Wilmington, Delaware, United States, Feb. 26, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global pediatric medical devices market was projected to attain US$ 27.6 billion in 2022. It is anticipated to garner a 6.3% CAGR from 2023 to 2031 and by 2031, the market is likely to ...
In Article Trend: Somewhat-Bullish
February 26, 2024 (12:01) / "Zacks Commentary" (by Zacks Equity Research)
3 Bridge Builder Mutual Funds for Great Returns
Consider investing in Bridge Builder mutual funds like BBVLX, BBVSX and BBGLX for impressive returns.
In Article Trend: Somewhat-Bullish
February 26, 2024 (09:58) / "Benzinga" (by Globe Newswire)
Implantable Loop Recorders Market Revenue to Reach USD 3.1 billion by 2031| Transparency Market Research, Inc.
Wilmington, Delaware, United States, Feb. 26, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global implantable loop recorders market was projected to attain US$ 1.3 billion in 2022. It is anticipated to garner a 10.2% CAGR from 2023 to 2031 and by 2031, the market is likely ...
In Article Trend: Somewhat-Bullish
February 25, 2024 (19:37) / "Motley Fool" (by Prosper Junior Bakiny)
If You Invested $10,000 in Medtronic in 2019, This Is How Much You Would Have Today
Medtronic is an excellent dividend-paying company.
In Article Trend: Somewhat-Bullish
February 22, 2024 (14:40) / "Benzinga" (by Globe Newswire)
Surgical Staplers Market Revenue to Reach USD 8.5 billion by 2031 | Says Transparency Market Research, Inc.
Wilmington, Delaware, United States, Feb. 22, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global surgical staplers market is estimated to flourish at a CAGR of 6.9% from 2023 to 2031.
In Article Trend: Bullish
February 22, 2024 (14:15) / "Motley Fool" (by David Jagielski)
Where Will Medtronic Stock Be in 3 Years?
Can this struggling medical device maker turn things around?
In Article Trend: Somewhat-Bullish
February 22, 2024 (12:21) / "Zacks Commentary" (by Zacks Equity Research)
5 Top No-Load Mutual Funds to Enhance Your Returns
Invest in no-load mutual funds like FIKAX, FSPCX, VSMIX, STSEX and BMIIX to ensure high returns.
In Article Trend: Neutral
February 22, 2024 (11:45) / "Motley Fool" (by Prosper Junior Bakiny)
2 Monster Stocks to Buy Without Any Hesitation
Investors can sleep easy at night with these stocks in their portfolios.
In Article Trend: Somewhat-Bullish
February 22, 2024 (11:25) / "Benzinga" (by Globe Newswire)
Ingestible Sensors Market Size to be Worth USD 1.5 billion by 2031, Growing 13.0% CAGR: Insights from Transparency Market Research, Inc.
Wilmington, Delaware, United States, Feb. 22, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global ingestible sensors market was projected to attain US$ 516.7 million in 2022. It is anticipated to garner a 13% CAGR from 2023 to 2031 and by 2031, the market is likely to attain ...
In Article Trend: Somewhat-Bullish
February 21, 2024 (16:40) / "Zacks Commentary" (by Zacks Equity Research)
MDT vs. LMAT: Which Stock Should Value Investors Buy Now?
MDT vs. LMAT: Which Stock Is the Better Value Option?
In Article Trend: Bullish
February 21, 2024 (16:30) / "Benzinga" (by Globe Newswire)
Flexible Endoscopes Market Is Expected To Reach A Value Of $12.9 Billion By 2028 At A CAGR Of More Than 7% As Per The Business Research Company's Flexible Endoscopes Global Market Report 2024
LONDON, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Flexible Endoscopes Global Market Report 2024, the flexible endoscopes market has experienced robust growth in recent years, fueled by advancements in medical technology and a rising prevalence of gastrointestinal ...
In Article Trend: Bullish
February 21, 2024 (16:30) / "Benzinga" (by Globe Newswire)
Esophageal Catheters Market Set for Strong Growth: Market Size To Reach $3.3 Billion By 2028 As Per The Business Research Company's Esophageal Catheters Global Market Report 2024
LONDON, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Esophageal Catheters Global Market Report 2024, the esophageal catheters market has demonstrated robust growth in recent years, driven by critical care advancements, increasing prevalence of cardiac and ...
In Article Trend: Somewhat-Bullish
February 21, 2024 (16:30) / "Benzinga" (by Globe Newswire)
Disposable Endoscopes Market Overview 2024-2028: Projected Market Size, Major Drivers And Leading Regions As Per The Business Research Company's Disposable Endoscopes Global Market Report 2024
LONDON, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the disposable endoscopes market, the disposable endoscopes industry has witnessed remarkable growth in recent years, driven by factors such as infection control, regulatory approvals, cost-efficiency, and ...
In Article Trend: Bullish
February 21, 2024 (16:30) / "Benzinga" (by Globe Newswire)
Esophagoscopes And Gastroscopes Market Is Set For Significant Growth At A Rate Of More Than 6% As Per The Business Research Company's Esophagoscopes And Gastroscopes Global Market Report 2024
LONDON, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's research on the esophagoscopes and gastroscopes market, the esophagoscopes and gastroscopes market has witnessed robust growth in recent years, driven by the prevalence of gastrointestinal disorders, an aging ...
In Article Trend: Somewhat-Bullish
February 21, 2024 (14:53) / "Motley Fool" (by Justin Pope)
Is Medtronic Stock a Buy Now?
A dividend legend is navigating some bumpy waters right now.
In Article Trend: Neutral
February 21, 2024 (14:23) / "Zacks Commentary" (by Zacks Equity Research)
February 21, 2024 (12:17) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Buy Zimmer Biomet ( ZBH ) Stock Now
Strategic plans to drive the Knee business bode well for Zimmer Biomet (ZBH).
In Article Trend: Somewhat-Bullish
February 21, 2024 (02:22) / "Motley Fool" (by Steve Symington)
Why Medtronic Stock Jumped Today
The medical device leader announced strong quarterly results and raised its full-year outlook.
In Article Trend: Somewhat-Bullish
February 21, 2024 (00:57) / "Associated Press"
Executive is convicted of insider trading related to medical device firm acquisition
ST. PAUL, Minn. ( AP ) - An executive at a medical device company has been convicted in Minnesota of insider trading for a scheme involving negotiations for the acquisition of the firm that was valued at $1.6 billion, federal prosecutors said Tuesday.
In Article Trend: Neutral
February 20, 2024 (19:19) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Q3 Earnings Beat Estimates, 2024 View Up
Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.
In Article Trend: Somewhat-Bullish
February 20, 2024 (17:30) / "Motley Fool" (by Motley Fool Transcribing)
Medtronic ( MDT ) Q3 2024 Earnings Call Transcript
MDT earnings call for the period ending December 31, 2023.
In Article Trend: Somewhat-Bullish
February 20, 2024 (17:14) / "Investors Business Daily" (by ALLISON GATLIN)
Biotech Crashes 64% After Unexpected Liver Failure Sidelines Two Tests
Biotech Stock Rapt Crashes 65% To Record Low After Side Effect Sidelines Two Clinical Studies Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
February 20, 2024 (16:30) / "Benzinga" (by Globe Newswire)
Anoscope Market Size Is Expected To Grow At A Rate Of More Than 6% Through 2024-2028 As Per The Business Research Company's Anoscope Global Market Report 2024
LONDON, Feb. 20, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Anoscope Global Market Report 2024, the anoscope market has witnessed robust growth in recent years, fueled by factors such as the prevalence of anorectal disorders, an aging population, and the increasing ...
In Article Trend: Bullish
February 20, 2024 (16:08) / "Investors Business Daily" (by Investor's Business Daily)
The Unexpected Setback That Sent This Biotech Tumbling
AXSM Stock Tumbles On An Unexpected Setback For Axsome's Alzheimer's Drug Investor's Business Daily ...
In Article Trend: Neutral
February 20, 2024 (15:45) / "Motley Fool" (by George Budwell)
4 Ultra-Safe Passive Income Vehicles to Buy and Hold Forever
These four dividend stocks won't keep you awake at night.
In Article Trend: Bullish
February 20, 2024 (14:24) / "Benzinga" (by Vandana Singh)
Why Is Medtronic Stock Trading Higher Today? - Medtronic ( NYSE:MDT )
Tuesday, Medtronic Plc MDT reported third-quarter 2024 sales of $8.1 billion, up 4.7% year-on-year ( Y/Y ) as reported and 4.6% organic, slightly beating the consensus of $7.95 billion.
In Article Trend: Bullish
February 20, 2024 (13:59) / "Investors Business Daily" (by Investor's Business Daily)
Medtronic Surges On Strong Beat, Outlook Boost
Medtronic Stock Surges After Easily Beating Quarterly Views. Raises Full-Year Outlook Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
February 20, 2024 (12:55) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Q3 Earnings and Revenues Beat Estimates
Medtronic (MDT) delivered earnings and revenue surprises of 3.17% and 1.73%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Somewhat-Bullish
February 20, 2024 (12:12) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Penumbra ( PEN ) Stock for Now
Investors remain optimistic for Penumbra (PEN), backed by the strength of its portfolio.
In Article Trend: Somewhat-Bullish
February 20, 2024 (11:45) / "PR Newswire" (by Medtronic plc)
Medtronic reports third quarter fiscal 2024 financial results
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business returns to growth; Raises full year guidance
In Article Trend: Somewhat-Bullish
February 20, 2024 (11:03) / "Zacks Commentary" (by Zacks Equity Research)
3 American Century Mutual Funds for Excellent Returns
Consider investing in American Century mutual funds like AFYDX, AGYWX and ALVDX for consistent performance.
In Article Trend: Somewhat-Bullish
February 20, 2024 (09:59) / "MarketWatch" (by Jamie Chisholm)
S&P 500 futures lower as Nvidia dips ahead of earnings midweek
U.S. stock-index futures moved lower as investors returned from the holiday weekend in cautious mood ahead of earnings reports that will shed light on the health of the consumer and crucial results from AI-darling Nvidia.
In Article Trend: Neutral
February 20, 2024 (09:56) / "Investing News Network" (by Investing News Network)
Making Earlier Detection of Ovarian Cancer a Reality
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business returns to growth; Raises full year guidance
In Article Trend: Bullish
February 20, 2024 (07:23) / "Benzinga" (by Avi Kapoor)
Medtronic Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Medtronic ( NYSE:MDT )
Medtronic plc MDT is expected to release earnings results for its third quarter of fiscal year 2024, before the opening bell on Feb. 20, 2024. Analysts expect the Dublin, Ireland-based company to report quarterly earnings at $1.26 per share, down from year-ago earnings of $1.3 per share.
In Article Trend: Neutral
February 20, 2024 (07:23) / "Business Insider" (by Avi Kapoor)
Medtronic Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Medtronic Gears Up For Q3 Print. Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ...
In Article Trend: Neutral
February 20, 2024 (06:00) / "PR Newswire" (by VentureBlick)
MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships and Multimillion-Dollar Investment
MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships ... PR ...
In Article Trend: Bullish
February 19, 2024 (11:25) / "PR Newswire" (by Coherent Market Insights)
Skin Excision Market to Reach $59.14 Billion by 2031 Owing to Increasing Prevalence of Skin Cancers and Advanced Healthcare Infrastructure | Says Coherent Market Insights
Skin Excision Market to Reach $59.14 Billion by 2031 Owing to Increasing Prevalence of Skin Cancers and Advanced ... PR ...
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website